Cargando…

Clinical and Economic Outcomes of Intravenous Brivaracetam Compared With Levetiracetam for the Treatment of Seizures in United States Hospitals

Background: Seizures are common among hospitalized patients. Levetiracetam (LEV), a synaptic vesicle protein 2A (SV2A) ligand, is a common intravenous (IV) anti-seizure medication option in hospitals. Brivaracetam (BRV), a selective SV2A ligand for treatment of focal seizures in patients ≥16 years,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beaty, Silky, Rosenthal, Ning A., Gayle, Julie, Dongre, Prashant, Ricchetti-Masterson, Kristen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667030/ https://www.ncbi.nlm.nih.gov/pubmed/34912285 http://dx.doi.org/10.3389/fneur.2021.760855

Ejemplares similares

Epidemiology and injectable antiseizure medication treatment patterns of seizure patients treated in United States hospitals
por: Beaty, Silky, et al.
Publicado: (2022)

Intravenous Brivaracetam in the Management of Acute Seizures in the Hospital Setting: A Scoping Review
por: Lee, Kiwon, et al.
Publicado: (2022)

Overnight switch from levetiracetam to brivaracetam. Safety and tolerability
por: Abraira, L., et al.
Publicado: (2021)

A Comparison of Seizure Prophylaxis: Phenytoin Versus Levetiracetam
por: Fiani, Brian, et al.
Publicado: (2021)

Levetiracetam and brivaracetam: a review of evidence from clinical trials and clinical experience
por: Steinhoff, Bernhard J., et al.
Publicado: (2019)

Role of Intravenous Levetiracetam in Acute Seizure Management
por: Kirmani, Batool
Publicado: (2014)

Economic Value of Adjunctive Brivaracetam Treatment Strategy for Focal Onset Seizures in Finland
por: Väätäinen, Saku, et al.
Publicado: (2019)

The Concurrent Use of Phenytoin and Levetiracetam for Seizure Prophylaxis in ICU Patients: The “Arrowhead Rationale”
por: Wong, Meghan, et al.
Publicado: (2023)

The Integrated Effects of Brivaracetam, a Selective Analog of Levetiracetam, on Ionic Currents and Neuronal Excitability
por: Hung, Te-Yu, et al.
Publicado: (2021)

Intravenous Levetiracetam for Treatment of Seizures in Term and Preterm Neonates
por: Karaoğlu, Pakize, et al.
Publicado: (2020)

Efficacy and Safety of Levetiracetam vs. Phenobarbital for Neonatal Seizures: A Systematic Review and Meta-Analysis
por: Qiao, Meng-Yuan, et al.
Publicado: (2021)

Discontinuation of Levetiracetam and Valproic Acid Due to Adverse Effects in Early Post-traumatic Seizure Prophylaxis
por: Pathak, Sami M, et al.
Publicado: (2023)

Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures
por: Lattanzi, Simona, et al.
Publicado: (2022)

Safety and efficacy of brivaracetam in children epilepsy: a systematic review and meta-analysis
por: Song, Ting, et al.
Publicado: (2023)

Brivaracetam: a novel antiepileptic drug for focal-onset seizures
por: Stephen, Linda J., et al.
Publicado: (2017)

First clinical postmarketing experiences in the treatment of epilepsies with brivaracetam: a retrospective observational multicentre study
por: Menzler, Katja, et al.
Publicado: (2019)

Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2022)

Brivaracetam and Levetiracetam Suppress Astroglial L-Glutamate Release through Hemichannel via Inhibition of Synaptic Vesicle Protein
por: Fukuyama, Kouji, et al.
Publicado: (2022)

Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From Germany
por: Willems, Laurent M., et al.
Publicado: (2018)

Effect of Brivaracetam on Efficacy and Tolerability in Patients With Brain Tumor-Related Epilepsy: A Retrospective Multicenter Study
por: Maschio, Marta, et al.
Publicado: (2020)

Role of Intravenous Levetiracetam in Seizure Prophylaxis of Severe Traumatic Brain Injury Patients
por: Kirmani, Batool F., et al.
Publicado: (2013)

Intravenous levetiracetam versus phenobarbital in children with status epilepticus or acute repetitive seizures
por: Lee, Yun-Jeong, et al.
Publicado: (2016)

Role of Levetiracetam in Neonatal Seizure
por: Murty, Yerramilli V.S.S., et al.
Publicado: (2012)

Treating Status Epilepticus: Phenytoin Versus Levetiracetam
por: Dell'Aquila, Jason, et al.
Publicado: (2021)

Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies
por: Ben-Menachem, Elinor, et al.
Publicado: (2016)

Levetiracetam for Pediatric Posttraumatic Seizure Prophylaxis
por: Nita, Dragos A., et al.
Publicado: (2016)

Can Matching-Adjusted Indirect Comparison Methods Mitigate Placebo Response Differences Among Patient Populations in Adjunctive Trials of Brivaracetam and Levetiracetam?
por: Swallow, Elyse, et al.
Publicado: (2017)

Rapidity of CNS Effect on Photoparoxysmal Response for Brivaracetam vs. Levetiracetam: A Randomized, Double-blind, Crossover Trial in Photosensitive Epilepsy Patients
por: Reed, Ronald C., et al.
Publicado: (2020)

Comparison of levetiracetam with phenytoin for the prevention of intravenous busulfan-induced seizures in hematopoietic cell transplantation recipients
por: Akiyama, Kana, et al.
Publicado: (2018)

Extrapolation of a Brivaracetam Exposure–Response Model from Adults to Children with Focal Seizures
por: Schoemaker, Rik, et al.
Publicado: (2017)

Efficacy and Tolerability of Intravenous Levetiracetam in Children
por: Aceves, Jose, et al.
Publicado: (2013)

Role of intravenous levetiracetam in status migrainosus
por: Farooq, Muhammad U., et al.
Publicado: (2007)

Intravenous levetiracetam in critically ill children
por: Incecik, Faruk, et al.
Publicado: (2016)

Pharmacokinetics, safety, and tolerability of intravenous brivaracetam in pediatric patients with epilepsy: An open‐label trial
por: Farkas, Mark Kristof, et al.
Publicado: (2022)

Efficacy and safety of levetiracetam in the management of seizures in neonates
por: Sedighi, Mostafa, et al.
Publicado: (2016)

Efficacy of levetiracetam for neonatal seizures in preterm infants
por: Han, Ji Yoon, et al.
Publicado: (2018)

Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures
por: Mumoli, Laura, et al.
Publicado: (2015)

Acute and long‐term effects of brivaracetam and brivaracetam–diazepam combinations in an experimental model of status epilepticus
por: Niquet, Jerome, et al.
Publicado: (2017)

Levetiracetam seizure prophylaxis in craniotomy patients at high risk for postoperative seizures
por: Gokhale, Sankalp, et al.
Publicado: (2013)

Cost-effectiveness analysis of intravenous levetiracetam versus intravenous phenytoin for early onset seizure prophylaxis after neurosurgery and traumatic brain injury
por: Kazerooni, Rashid, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_vm3nj8rq6m8msshone9fc1plj0